138 related articles for article (PubMed ID: 9739098)
21. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
[TBL] [Abstract][Full Text] [Related]
22. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.
Wallace TL; Gudelsky GA; Vorhees CV
Synapse; 2001 Jan; 39(1):1-7. PubMed ID: 11071703
[TBL] [Abstract][Full Text] [Related]
23. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
Bowyer JF; Davies DL; Schmued L; Broening HW; Newport GD; Slikker W; Holson RR
J Pharmacol Exp Ther; 1994 Mar; 268(3):1571-80. PubMed ID: 8138969
[TBL] [Abstract][Full Text] [Related]
24. N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.
Swanepoel T; Möller M; Harvey BH
Psychopharmacology (Berl); 2018 Jan; 235(1):351-368. PubMed ID: 29116368
[TBL] [Abstract][Full Text] [Related]
25. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
Lowy MT; Novotney S
Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
[TBL] [Abstract][Full Text] [Related]
26. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine.
Abekawa T; Ohmori T; Koyama T
Brain Res; 1997 Aug; 767(1):34-44. PubMed ID: 9365013
[TBL] [Abstract][Full Text] [Related]
27. Effect of alpha-tocopherol and deferoxamine on methamphetamine-induced neurotoxicity.
Park MJ; Lee SK; Lim MA; Chung HS; Cho SI; Jang CG; Lee SM
Brain Res; 2006 Sep; 1109(1):176-82. PubMed ID: 16844102
[TBL] [Abstract][Full Text] [Related]
28. Pre-administration of low-dose methamphetamine enhances movement and neural activity after high-dose methamphetamine administration in the striatum.
Takeichi T; Hori O; Hattori T; Kiryu K; Zuka M; Kitamura O
Neurosci Lett; 2019 Jun; 703():119-124. PubMed ID: 30885634
[TBL] [Abstract][Full Text] [Related]
29. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
30. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
31. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic Neuron-Specific Deletion of p53 Gene Attenuates Methamphetamine Neurotoxicity.
Lu T; Kim PP; Greig NH; Luo Y
Neurotox Res; 2017 Aug; 32(2):218-230. PubMed ID: 28342134
[TBL] [Abstract][Full Text] [Related]
33. Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat.
Brennan KA; Colussi-Mas J; Carati C; Lea RA; Fitzmaurice PS; Schenk S
Brain Res; 2010 Mar; 1317():137-46. PubMed ID: 19962371
[TBL] [Abstract][Full Text] [Related]
34. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
Abekawa T; Ohmori T; Koyama T
Brain Res; 1994 Apr; 643(1-2):276-81. PubMed ID: 7518327
[TBL] [Abstract][Full Text] [Related]
35. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat.
Wallace TL; Gudelsky GA; Vorhees CV
J Neurosci; 1999 Oct; 19(20):9141-8. PubMed ID: 10516332
[TBL] [Abstract][Full Text] [Related]
36. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
[TBL] [Abstract][Full Text] [Related]
37. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
[TBL] [Abstract][Full Text] [Related]
38. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum.
Theodore S; Cass WA; Maragos WF
Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141
[TBL] [Abstract][Full Text] [Related]
39. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum.
Pu C; Vorhees CV
Brain Res Dev Brain Res; 1993 Apr; 72(2):325-8. PubMed ID: 8097974
[TBL] [Abstract][Full Text] [Related]
40. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Nash JF; Yamamoto BK
Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
